Kyverna Therapeutics shares are falling Friday. The company released a presentation on KYV-101, its CD19 CAR T-cell candidate. Here's a look at the details:
VinFast shares surge as the company anticipates sustained growth, nearing break-even point, and eyes expansion into the US electric vehicle market amidst fierce competition.
While some expected a close vote on Elon Musk's pay compensation plan, the official results showed overwhelming support. Here's what analysts are saying.
Nucor Corporation's shares are dropping as its second-quarter outlook falls short of expectations, citing lower earnings due to decreased average selling prices and lackluster volumes in steel segments.